The economic consequences of irritable bowel syndrome: a US employer perspective.
about
Physical activity for treatment of irritable bowel syndromeAcupuncture for treatment of irritable bowel syndromeAcupuncture for treatment of irritable bowel syndromePsychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based studyRandomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind studyDifferent faces of gastroparesis.Comprehensive self-management for irritable bowel syndrome: randomized trial of in-person vs. combined in-person and telephone sessionsEstimating the burden of irritable bowel syndrome: analysis of a nationwide korean database.Acupuncture for irritable bowel syndrome: a protocol for a pragmatic randomised controlled trial.Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study.Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.An experience with the Patient-Reported Outcomes Measurement Information System: pros and cons and unanswered questionsSymptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.Obstructive defecation in middle-aged women.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness.Latent structure of irritable bowel syndrome symptom severity.Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndromeBacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controlsKnowledge, attitudes, and practices of primary care physicians about irritable bowel syndrome in Northern Saudi ArabiaAn Initial Attack of Urinary Stone Disease Is Associated with an Increased Risk of Developing New-Onset Irritable Bowel Syndrome: Nationwide Population-Based Study.Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective.Updates on treatment of irritable bowel syndrome.Update on irritable bowel syndrome and gender differences.Integrative medicine in gastrointestinal disease: evaluating the evidence.Cognitive-behavioral therapy for the management of irritable bowel syndromeEconomic burden of irritable bowel syndrome in China.Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome.Linaclotide: a novel therapy for chronic constipation and constipation-predominant irritable bowel syndrome.New treatments for IBS.New and Investigational Agents for Irritable Bowel Syndrome.Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service.Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome.Physiology of Visceral Pain.General practitioners' perceptions of irritable bowel syndrome: a Q-methodological study.Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.Effects of Transcranial Direct Current Stimulation, Transcranial Pulsed Current Stimulation, and Their Combination on Brain Oscillations in Patients with Chronic Visceral Pain: A Pilot Crossover Randomized Controlled Study.
P2860
Q24186828-86A889F7-3D20-4EAC-8F84-7EA3331F2173Q24244050-4C2A68B4-5F76-4EA5-9268-36465061247CQ24245342-A6247725-0D4D-433B-AA42-354FE6FC8AAEQ24811008-11755E65-0F48-4A13-984E-619E892FE2EEQ28239840-F12820CF-75F8-4AA5-804A-F263585917ECQ33555343-37F5F7D1-B5B3-4848-B95F-F24AFE3BBE32Q33580837-CD481645-D02D-4C51-8BBA-238F1BCD7C06Q33586874-313E31FB-1118-4FED-80B7-4F9BF45A53BEQ33610964-75E89B3C-6A11-4ACD-A96D-2E2308E4EEAAQ33648576-110E2DB4-1BD1-42B5-9645-3F9A8240F6BFQ33958710-02D399D6-908E-4B0C-B43F-BA51F070A4C4Q34179472-004E6AB3-6156-4A23-B0AB-08EC7F4EDD09Q34204371-657A2819-F52F-4B79-BAC2-A9078FC5185EQ34394157-66D83789-0A6B-470C-AE89-77F17CF85DEBQ34423405-3942EEB2-BC22-4A88-A752-DA6F74ABF9DBQ34536435-98CB01AD-6EBB-4BC7-A671-E0EB9136D28EQ34626602-CA776F65-1A5A-4E54-B273-96FF62E6EA46Q34627613-6B2C70C9-6C81-4A31-B7A9-4310B29FAD18Q34827497-4378B1F0-E171-4DFD-9307-478EF74CC590Q35061903-5D36B135-2924-48AF-8BB2-60EEE4E9F390Q35155933-EC9EA079-201D-4CA5-97EF-80DFC30F7274Q35268912-A892A7FF-D212-446A-A11E-0350E178F7A9Q36020927-F352C31B-E348-49BB-8C3A-2878B9254370Q36060265-FDB21470-ADC4-4D81-9144-4FFC5346DCEDQ36536707-A16724A6-FAF4-4C32-8D92-48F64694EB54Q37156627-BC837DC8-147E-4FDD-87EB-982D0D868EB6Q37205403-E66B9291-ACD5-418E-882A-5545C32417D5Q37345889-3C7041BC-3629-4B5C-A893-C3534ACD0262Q37408834-5ADD3D3C-CD8E-4B88-ACAD-59C63A16B46AQ37522698-A225FA13-3C85-4E94-8719-DB1BEEA348DBQ37569891-74B5A430-823B-446D-A8C9-5B89E7EC725FQ37671189-D2B92E4A-E974-4601-9556-F183AA44C3EEQ38059436-B847610E-FA60-4E15-A9EB-D5BCEB97ED07Q38601834-A59E5B8B-D3B0-423D-B2D0-AFFDAAAB9DFAQ38608981-51D4C968-814B-458C-A8EB-63E6D441531FQ38679545-5A529803-B5D4-4B3B-8B4F-C3BA6AB6E457Q38991459-718A5B7B-FE39-4CB3-929D-C1A32B884EE2Q42695425-86BC4DD3-DCCD-45E1-B4FB-4F01842EFA2FQ46674888-FCE0F324-687B-47FC-8138-0ADEC20C85EAQ47140186-01E8314F-BF63-4F5A-BA12-9D9EDBA67F98
P2860
The economic consequences of irritable bowel syndrome: a US employer perspective.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The economic consequences of irritable bowel syndrome: a US employer perspective.
@ast
The economic consequences of irritable bowel syndrome: a US employer perspective.
@en
The economic consequences of irritable bowel syndrome: a US employer perspective.
@nl
type
label
The economic consequences of irritable bowel syndrome: a US employer perspective.
@ast
The economic consequences of irritable bowel syndrome: a US employer perspective.
@en
The economic consequences of irritable bowel syndrome: a US employer perspective.
@nl
prefLabel
The economic consequences of irritable bowel syndrome: a US employer perspective.
@ast
The economic consequences of irritable bowel syndrome: a US employer perspective.
@en
The economic consequences of irritable bowel syndrome: a US employer perspective.
@nl
P2093
P1476
The economic consequences of irritable bowel syndrome: a US employer perspective.
@en
P2093
Crystal E Thibeault
Feride Frech
Howard G Birnbaum
Joshua J Ofman
Rym Ben-Hamadi
Stephanie A Leong
Victoria Barghout
P304
P356
10.1001/ARCHINTE.163.8.929
P407
P577
2003-04-01T00:00:00Z